You are here

Australian Regulatory Guidelines for Prescription Medicines (ARGPM) BETA

The ARGPM is a collection of guidance documents and other information about the regulation of prescription medicines. The ARGPM has been designed for use by sponsors to provide a way to search for relevant TGA guidance documents about prescription medicines from a single location. Commonly used ARGPM documents, including basic information, CTD and general dossier requirements and forms, can be found at medicine registration fundamentals.

This is a beta version of the new ARGPM and we welcome your feedback while the new tool is being tested. The previous version of the ARGPM will remain available for a short time.

To use the ARGPM, filter the list of documents by selecting topics, sub-topics or tags, or search using keywords. The search or filtered results are limited to relevant items within the ARGPM. If you cannot find the document you are looking for you can search the entire website using the main site search.

Latest updates - 25 September 2021
September
25
2021

Information regarding the export of therapeutic medicines, medical devices and human substances

September
24
2021

This guidance is to assist entities and individuals planning to export medicines (including prescription, over-the-counter and complementary medicines) either for commercial supply, or for non-commercial purposes (for example, for a family member or friend).

September
16
2021

Information about the Australia-Canada-Singapore-Switzerland (ACSS) Consortium

Filters

Type

Showing 1 - 10 of 13
12 July 2013

Fees payable and timeframes for different types of prescription medicine applications

Tags: 
fees/payments
12 July 2013

Guidance on submitting the Certified Product Details (CPD) for prescription medicines

Tags: 
chemicals, variations
16 October 2019

Guidance on the regulatory requirements for therapeutic goods that contain, or are produced from, human blood or plasma

Tags: 
blood, variations, eCTD, electronic submissions, DMF
9 August 2013

Guidance on the two mechanisms to provide information about a drug substance sourced from a third-party manufacturer

Tags: 
variations
6 March 2017

Guidance for sponsors on demonstrating stability of medicines under Australian conditions

Tags: 
testing
4 October 2019

Data requirements for formulation changes to inhalation and nasal spray medicines

Tags: 
generic medicines, variations
8 October 2020

If sponsorship is transferred to you, you need to notify the TGA

Tags: 
ARTG
3 October 2018

Guidance on the process for registering new medicines with new trade names that are 'clones' of currently registered prescription medicines

30 April 2018

Types of change where notification is sufficient

Tags: 
variations
10 July 2019

How to make variations to existing ARTG entries for prescription medicines

Tags: 
variations, chemical entities, biological medicines, generic medicines

Pages